Infectious diseases Archives - Page 2 of 29

Podcasts

RSV – A serious adult disease worth preventing

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Clinical Articles

COVID is surging – What should we expect?

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

Podcasts

RSV in adults

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

Podcasts

RSV – More serious than you think

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

Podcasts

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

Podcasts

COVID update – New vaccines and what’s happening in China?

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

Podcasts

COVID update – The current COVID wave

The current COVID wave, the latest news on vaccines and antivirals, and long COVID guidelines.

Clinical Articles

How worried should we be about the pneumonia outbreak in China?

Reports of a surge in pneumonia-like illness primarily affecting children in northern China have captured our attention...

Clinical Articles

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

Videos

Molnupiravir oral anti-viral for COVID-19

In this Product Explainer, Infectious Diseases Physician and Microbiologist A/Prof Paul Griffin explains the role of oral anti-virals in the context of the current COVID-19 virology and available therapies.

Podcasts

COVID & the elderly

COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.

Clinical Articles

We’re in a new COVID wave. What can we expect this time?

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Infectious diseases

RSV – A serious adult disease worth preventing

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

COVID is surging – What should we expect?

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

RSV in adults

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

RSV – More serious than you think

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

RSV – Past, present & future

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

COVID update – New vaccines and what’s happening in China?

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

COVID update – The current COVID wave

The current COVID wave, the latest news on vaccines and antivirals, and long COVID guidelines.

How worried should we be about the pneumonia outbreak in China?

Reports of a surge in pneumonia-like illness primarily affecting children in northern China have captured our attention...

‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

Molnupiravir oral anti-viral for COVID-19

In this Product Explainer, Infectious Diseases Physician and Microbiologist A/Prof Paul Griffin explains the role of oral anti-virals in the context of the current COVID-19 virology and available therapies.

COVID & the elderly

COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.

We’re in a new COVID wave. What can we expect this time?

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Get the app

Site

Company

Connect

Legal

Healthed

Infectious diseases

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Do you have family members or friends sick with a respiratory infection? If so, there’s a good chance it’s COVID, caused by the JN.1 variant currently circulating in Australia.

Important to highlight and make people aware of RSV and where it sits, and vaccines for patients over the age of 60 are coming, pending approval

RSV is a big problem in young children, under one’s and older patients. There is a significance in over 60, the mortality and morbidity does seem to increase. Vaccine fatigue is also a significant deterrent to overcome in general practice.

RSV is a very important cause of disease for young children and older adults in winter season (May – September). Understand the natural course of the disease, and advice to give parents.

What’s happening in China now? Multiresistant mycoplasma infection may be the issue, ad the latest on new COVID vaccines arriving next week and in the next few months

The current COVID wave, the latest news on vaccines and antivirals, and long COVID guidelines.

Reports of a surge in pneumonia-like illness primarily affecting children in northern China have captured our attention...

Antimicrobial resistance is one of the biggest global threats to health, food security and development...

In this Product Explainer, Infectious Diseases Physician and Microbiologist A/Prof Paul Griffin explains the role of oral anti-virals in the context of the current COVID-19 virology and available therapies.

COVID is still very much around, and older people are still most at risk of significant morbidity. We discuss management strategies, both in the community and in facilities, that can be beneficial in mitigating this risk.

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Get the app

Site

Company

Connect

Legal

Extra Details

Healthed